AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Atezolizumab in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Tecentriq 1200 mg/20 mL** Concentrate for solution for infusion | A6-100034 | Roche Products Limited | active | 27 Oct 2026 |
| Tecentriq 840 mg/14 mL** Concentrate for solution for infusion | A6-100033 | Roche Products Limited | active | 27 Oct 2026 |
Atezolizumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Atezolizumab, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Atezolizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.